Suprascapular Nerve Block versus Steroid Injection for Non-Specific Shoulder Pain

Objectives: To compare the mean improvement in pain on Visual Analogue Scale by Suprascapular Nerve block and Intra-articular steroid injection in patients with hemiplegic shoulder pain. Study Design: Randomized Controlled Trial Place and Duration of Study: Pain Clinic, Armed Forces Institute of Rehabilitation Medicine Rawalpindi from 25th October 2017 to 24th April 2018 Patients & Methods: 60 patients with CVA and shoulder pain on hemiplegic side for at least 2 weeks were included in study after non-probability consecutive sampling after meeting inclusion criteria. Subjects were randomized by lottery into two groups; Group A receiving Suprascapular Nerve block with 5ml of 1% Lignocaine with Group B receiving Intra-articular 40mg Triamcinolone Acetonide plus 1 ml of 1% Lignocaine injections. Mean change in pain scores on VAS was calculated between score at baseline and at 4 weeks post-intervention Results: The mean age of patients in group A was 59.17 ± 9.81 years and in group B was 39.96 ± 11.11 years. Out of 60 patients, 34 (56.67%) were males and 26 (43.33%) were females with male to female ratio of 1.3:1. Mean duration of stroke was 7.50 ± 2.66 months. Mean pain change on VAS in Group A (Suprascapular Nerve block) was 3.83 ± 1.12 cm while in Group B (Intra-articular steroid injection) it was 2.17 ± 0.99 cm (p-value = 0.0001). Conclusion: This study concluded that Suprascapular Nerve block offered better improvement in hemiplegic shoulder pain on Visual Analogue Scale at 4 weeks as compared to intraarticular steroid injection.

Download Full-text

Afferent inhibition and cortical silent periods in shoulder primary motor cortex and effect of a suprascapular nerve block in people experiencing chronic shoulder pain

Clinical Neurophysiology ◽

10.1016/j.clinph.2015.03.012 ◽

2016 ◽

Vol 127 (1) ◽

pp. 769-778 ◽

Cited By ~ 6

Author(s):

Lynley Bradnam ◽

E. Michael Shanahan ◽

Kirsty Hendy ◽

Amalia Reed ◽

Tegan Skipworth ◽

...

Keyword(s):

Motor Cortex ◽

Shoulder Pain ◽

Nerve Block ◽

Primary Motor Cortex ◽

Suprascapular Nerve ◽

Afferent Inhibition ◽

Suprascapular Nerve Block ◽

Chronic Shoulder Pain

Download Full-text

ULTRA-SOUND GUIDED SUPRASCAPULAR NERVE BLOCK IN HEMIPLEGIC SHOULDER PAIN

Journal of Evidence Based Medicine and Healthcare ◽

10.18410/jebmh/2018/657 ◽

2018 ◽

Vol 5 (46) ◽

pp. 3228-3232

Author(s):

Swapnil Pramod Sonune ◽

Anil Kumar Gaur ◽

Shefali Gupta

Keyword(s):

Shoulder Pain ◽

Nerve Block ◽

Suprascapular Nerve ◽

Ultra Sound ◽

Suprascapular Nerve Block

Download Full-text

Effectiveness of Suprascapular Nerve Block in the Treatment of Hemiplegic Shoulder Pain: A Systematic Review and Meta-Analysis

Frontiers in Neurology ◽

10.3389/fneur.2021.723664 ◽

2021 ◽

Vol 12 ◽

Author(s):

Yajing Hou ◽

Yong Wang ◽

Xiaojing Sun ◽

Yake Lou ◽

Ying Yu ◽

...

Keyword(s):

Systematic Review ◽

Shoulder Pain ◽

Nerve Block ◽

External Rotation ◽

Meta Analysis ◽

Suprascapular Nerve ◽

Cochrane Library ◽

Control Group ◽

Suprascapular Nerve Block ◽

Secondary Endpoints

Purpose: We aimed to investigate the effectiveness of suprascapular nerve block (SSNB) in patients with hemiplegic shoulder pain (HSP).Background: SSNB is widely used in various shoulder pains, but whether it is effective in HSP remains unknown.Methods: PubMed, Cochrane Library, and Embase databases were searched to identify potential citations. Randomized controlled trials meeting the eligible criteria were included in our analysis. The primary endpoint was Visual Analog Scale (VAS) with a maximum value of 100 and a minimum value of 0. Secondary endpoints were passive range of motion (PROM) that pain starts, and the PROM mainly included abduction, flexion, and external rotation. In addition, the upper extremity Fugl-Meyer assessment (FMA) was also included in our secondary endpoints.Results: Eight studies with 281 patients were included in our analysis. For VAS, there was no obvious difference between SSNB group and control group regardless of the follow-up period (<4 weeks or ≥4 weeks), which were −6.62 (−15.76, 2.53; p = 0.16) and 1.78 (−16.18, 19.74; p = 0.85). For shoulder function, the PROM of abduction, flexion, and external rotation was similar between groups. However, motor function indicator FMA is lower in SSNB control than that in control group, with a mean difference (and 95% CI) of −2.59 (−4.52, −0.66; p = 0.008).Conclusion: SSNB is an effective way for HSP patients.Systematic Review Registration: Registration ID: CRD42021252429.

Download Full-text

Efficacy and safety of ultrasound-guided suprascapular nerve block in patients with chronic shoulder pain☆

Colombian Journal of Anesthesiology ◽

10.1097/01819236-201341020-00005 ◽

2013 ◽

Vol 41 (2) ◽

pp. 104-108

Author(s):

Mario Andrés Arcila Lotero ◽

Roberto Carlo Rivera Díaz ◽

Daniel Campuzano Escobar ◽

María Adelaida Mejía Aguilar ◽

Sandra Milena Martínez Ramírez

Keyword(s):

Shoulder Pain ◽

Nerve Block ◽

Suprascapular Nerve ◽

Efficacy And Safety ◽

Ultrasound Guided ◽

Suprascapular Nerve Block ◽

Chronic Shoulder Pain

Download Full-text

A case series of suprascapular nerve block (with an historical comparator) for shoulder pain in motor neurone disease

Palliative Medicine ◽

10.1177/0269216320929553 ◽

2020 ◽

Vol 34 (8) ◽

pp. 1127-1133

Author(s):

E Michael Shanahan ◽

Karen Glaezter ◽

Tiffany Gill ◽

Catherine Hill ◽

Scott Graf ◽

...

Keyword(s):

Shoulder Pain ◽

Nerve Block ◽

Case Series ◽

Suprascapular Nerve ◽

Motor Neurone ◽

Motor Neurone Disease ◽

Control Group ◽

Placebo Control ◽

Time Interval ◽

Suprascapular Nerve Block

Background: Shoulder pain is a distressing but under-reported and poorly managed symptom in people with motor neurone disease. Objectives: This study aimed to assess the efficacy of suprascapular nerve block for the management of shoulder pain in patients with motor neurone disease. Methods: A total of 27 patients with motor neurone disease and shoulder pain were offered a suprascapular nerve block. Ten of these patients had bilateral shoulder pain and both were injected, making a total of 37 shoulders. The patients were followed up for a total of 3 months, or until death. Shoulder pain was measured using the pain scale (out of 100) of the shoulder pain and disability index and compared with baseline scores and a placebo control group from an earlier study using the same methodology (ACTRN12619000353190). Results: Following the nerve block there was a significant improvement of pain scores from baseline (58.4) at week 1 (20.8, p < 0.000), week 6 (17.6, p < 0.000) and week 12 (30.4, p = 0.001) and a significant improvement compared with the control group across each time interval. Conclusion: Suprascapular nerve block is a safe, effective therapy for patients with chronic shoulder pain.

Download Full-text